Nuclear disarmament group hopes Nobel Prize will combat apathy
Corrects misspelling of 'nuclear' in headline
GENEVA, Oct 11 (Reuters) -A coalition campaigning against nuclear weapons said on Friday that it hoped the award of the Nobel Peace Prize to the Japanese organisation Nihon Hidankyo would counter apathy surrounding the growing risk of their use.
The Geneva-based International Campaign to Abolish Nuclear Weapons (ICAN) won the Peace Prize in 2017 for its efforts to promote compliance with the U.N. Treaty on the Prohibition of Nuclear Weapons.
Daniel Hogsta, its deputy director, told Reuters he was "absolutely thrilled" for Nihon Hidankyo, representing atomic bomb survivors from Hiroshima and Nagasaki.
"It couldn't have come at a better time," he said. "I mean, it is generally recognised that the risk of the use of nuclear weapons right now is as high or perhaps even higher than it's ever been."
He cited the Ukraine war, where Russia has been warning that growing Western involvement increases the danger that it could resort to nuclear weapons.
"But there's unfortunately too much apathy," Hogsta said. "And what Nihon Hidankyo have shown us, and why this award is so important, is that people and political leaders need to be motivated for action."
ICAN is a coalition of non-governmental organisations from around 100 countries that lobbied successfully for the adoption of the nuclear weapons ban treaty, which 73 countries have ratified.
"We will continue to work closely with Nihon Hidankyo and Hibakusha across the world to make sure that the treaty is the game changer that it has the potential to be," Hogsta said.
Reporting by Cecile Mantovani; Writing by Emma Farge; Editing by Kevin Liffey
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
